NMRA financial statements and SEC filings
NMRA annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | – | -$241.16M | -$236.93M | 10-K |
| 2024-12-31 | – | -$263.46M | -$243.79M | 10-K |
| 2023-12-31 | – | -$252.10M | -$235.93M | 10-K |
| 2022-12-31 | – | -$135.87M | -$130.90M | 10-K |
NMRA annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $191.05M | $87.18M | $103.87M | 10-Q |
| 2024-12-31 | $316.97M | $29.91M | $287.06M | 10-K |
| 2023-12-31 | $496.19M | $27.12M | $469.08M | 10-K |
| 2022-12-31 | $426.23M | $29.40M | -$446.85M | 10-K |
NMRA annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | -$206.44M | – | $77.09M | 10-K |
| 2024-12-31 | -$182.94M | – | $21.60M | 10-K |
| 2023-12-31 | -$163.28M | -$117.00K | $231.94M | 10-K |
| 2022-12-31 | -$114.90M | -$511.00K | $115.74M | 10-K |